亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

南京肽業生物科技有限公司多肽  

多肽,氨基酸

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 83150-76-9|醋酸奧曲肽
83150-76-9|醋酸奧曲肽
單價 面議對比
詢價 暫無
發貨 江蘇付款后3天內
品牌 南京肽業
過期 長期有效
更新 2020-11-05 13:59
 
詳細信息

中文名稱:

醋酸奧曲肽

中文同義詞:

醋酸奧曲肽;

[R-(R^<*>^,R^<*>^)]-D-苯丙酰-L-半胱氨酰-L-苯丙酰-D-色胺酰-L-賴氨酰-1-蘇氨酰-N-[2-羥基-1-(羥基甲基)丙基]-L-蘇氨酰胺環(2→7)二硫化物;醋酸奧曲肽 OCTREOTIDEACETATE;醋酸奧曲肽 83150-76-9

英文名稱:

Octreotide acetate

英文同義詞:

DARAMONOL;

L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*));

ctreotide;

Ocetreotide, Acetate;

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl-, cyclic (2?7)-disulfide;OXTREOTIDE;[R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;

Octreotide acetate

CAS:

83150-76-9

分子式:

C49H66N10O10S2

分子量:

1019.24


©2025 南京肽業生物科技有限公司多肽 版權所有   技術支持:化工網   訪問量:5126  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |